Skip to Content

Albiglutide

In the US, Albiglutide (albiglutide systemic) is a member of the drug class incretin mimetics and is used to treat Diabetes, Type 2.

US matches:

Scheme

Rec.INN

ATC (Anatomical Therapeutic Chemical Classification)

A10BJ04

CAS registry number (Chemical Abstracts Service)

0782500-75-8

Chemical Formula

C3232-H5032-N864-O979-S41

Molecular Weight

72970

Therapeutic Category

Antidiabetic agent: Incretin-mimetic, glucagon-like peptide-1 (GLP-1) agonist

Chemical Name

([8-glycine]human glucagon-like peptide 1-(7-36)-peptidyl)([8-glycine]human glucagon-like peptide 1-(7-36)-peptidyl)(human serum albumin (585 residues)) (WHO)

Foreign Names

  • Albiglutidum (Latin)
  • Albiglutid (German)
  • Albiglutide (French)
  • Albiglutida (Spanish)

Generic Names

Brand Names

  • Eperzan
    Glaxo Operations UK, United Kingdom; GlaxoSmithKline, Switzerland; GlaxoSmithKline, Germany; GlaxoSmithKline, Poland; GSK, Belgium
  • Tanzeum
    GlaxoSmithKline, United States

International Drug Name Search

Glossary

TermDefinition
ISInofficial Synonym
JANJapanese Accepted Name
OSOfficial Synonym
PHPharmacopoeia Name
Rec.INNRecommended International Nonproprietary Name (World Health Organization)
USANUnited States Adopted Name
WHOWorld Health Organization

Click for further information on drug naming conventions and International Nonproprietary Names.

Important Notice: The Drugs.com international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.

Hide